Imipenem underdosing as a cause of persistent neutropenic fever?

Journal of Antimicrobial Chemotherapy

Volumn 64, Issue 3, 2009, Pages 665-667

  Lamoth, Frédéric ^a   Buclin, Thierry ^b   Pascual, Andres ^a   Calandra, Thierry ^a   Marchetti, Oscar ^a  

^a LAUSANNE UNIVERSITY HOSPITAL   (Switzerland)

^b UNIVERSITY OF LAUSANNE   (Switzerland)

Author keywords

Blood concentrations; Febrile neutropenia; Persistent fever

Indexed keywords

IMIPENEM;

ADULT; AGED; ANTIMICROBIAL THERAPY; CONTINUOUS INFUSION; DOSE KIDNEY FUNCTION RELATION; DRUG BLOOD LEVEL; DRUG DOSE INCREASE; DRUG DOSE REGIMEN; DRUG TREATMENT FAILURE; FEBRILE NEUTROPENIA; FEMALE; FEVER; HUMAN; LETTER; LEUKEMIA; MALE; MINIMUM INHIBITORY CONCENTRATION; PERSISTENT INFECTION; RETROSPECTIVE STUDY;

ADULT; AGED; ANTI-BACTERIAL AGENTS; BACTERIAL INFECTIONS; FEMALE; FEVER; HUMANS; IMIPENEM; MALE; MIDDLE AGED; NEUTROPENIA;

EID: 69049093939     PISSN: 03057453     EISSN: 14602091     Source Type: Journal    
DOI: 10.1093/jac/dkp233     Document Type: Letter

References (8)

1. Klastersky JA. Use of imipenem as empirical treatment of febrile neutropenia. Int J Antimicrob Agents 2003; 21: 393-402.
2. Hughes WT, Armstrong D, Bodey GP et al. 2002 guidelines for the use of antimicrobial agents in neutropenic patients with cancer. Clin Infect Dis 2002; 34: 730-51.
3. Mouton JW, Touzw DJ, Horrevorts AM et al. Comparative pharmacokinetics of the carbapenems: Clinical implications. Clin Pharmacokinet 2000; 39: 185-201.
4. Ariano RE, Nyhlen A, Donnelly JP et al. Pharmacokinetics and pharmacodynamics of meropenem in febrile neutropenic patients with bacteremia. Ann Pharmacother 2005; 39: 32-8.
5. Lortholary O, Lefort A, Tod M et al. Pharmacodynamics and pharmacokinetics of antibacterial drugs in the management of febrile neutropenia. Lancet Infect Dis 2008; 8: 612-20.
6. Lamoth F, Buclin T, Csajka C et al. Reassessment of recommended imipenem doses in febrile neutropenic patients with hematological malignancies. Antimicrob Agents Chemother 2009; 53: 785-7.
7. Navas D, Caillon J, Batard E et al. Trough serum concentrations of β-lactam antibiotics in cancer patients: Inappropriateness of conventional schedules to pharmacokinetic/pharmacodynamic properties of β-lactams. Int J Antimicrob Agents 2006; 27: 102-7.
8. Giannoni E, Moreillon P, Cotting J et al. Prospective determination of plasma imipenem concentrations in critically ill children. Antimicrob Agents Chemother 2006; 50: 2563-8.